Multiplex digital profiling of DNA methylation heterogeneity for sensitive and cost-effective cancer detection in low-volume liquid biopsies
Science Advances · 2024
DOI: 10.1126/sciadv.adp1704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Yang Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA. Hauptthemen laut MEDLINE: DNA Methylation, Biomarkers, Tumor, Lung Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Molecular alterations in cancerous tissues exhibit intercellular genetic and epigenetic heterogeneity, complicating the performance of diagnostic assays, particularly for early cancer detection. Conventional liquid biopsy methods have limited sensitivity and/or ability to assess epigenetic heterogeneity of rare epiallelic variants cost-effectively. We report an approach, named REM-DREAMing (Ratiometric-Encoded Multiplex Discrimination of Rare EpiAlleles by Melt), which leverages a digital microfluidic platform that incorporates a ratiometric fluorescence multiplex detection scheme and precise digital high-resolution melt analysis to enable low-cost, parallelized analysis of heterogeneous methylation patterns on a molecule-by-molecule basis for the detection of cancer in liquid biopsies. We applied the platform to simultaneously assess intermolecular epigenetic heterogeneity in five methylation biomarkers for improved, blood-based screening for early-stage non–small cell lung cancer. In a cohort of 48 low-volume liquid biopsy specimens from patients with indeterminant pulmonary nodules, we show that assessment of intermolecular methylation density distributions can notably improve the performance of multigene methylation biomarker panels for the early detection of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
- Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
- Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.
- Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218, USA.
- Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA.
ORCID-Profile: Yang Zhao, Christine M O'Keefe, Conor M Allan, Hanran Lei, Allyson Chiu, Kuangwen Hsieh, Tza-Huei Wang
Förderung
- NCI NIH HHS
Zitieren
APA
Zhao, Y., O'Keefe, C. M., Hu, J., Allan, C. M., Cui, W., Lei, H., Chiu, A., Hsieh, K., Joyce, S. C., Herman, J. G., Pisanic, T. R., & Wang, T. H. (2024). Multiplex digital profiling of DNA methylation heterogeneity for sensitive and cost-effective cancer detection in low-volume liquid biopsies. Science Advances. https://doi.org/10.1126/sciadv.adp1704
Vancouver
Zhao Y, O'Keefe CM, Hu J, Allan CM, Cui W, Lei H, et al. Multiplex digital profiling of DNA methylation heterogeneity for sensitive and cost-effective cancer detection in low-volume liquid biopsies. Science Advances. 2024. doi:10.1126/sciadv.adp1704
BibTeX
@article{Zhao2024,
author = {Zhao, Yang and O'Keefe, Christine M and Hu, Jiumei and Allan, Conor M and Cui, Weiwen and Lei, Hanran and Chiu, Allyson and Hsieh, Kuangwen and Joyce, Sonali C and Herman, James G and Pisanic, Thomas R and Wang, Tza-Huei},
title = {Multiplex digital profiling of DNA methylation heterogeneity for sensitive and cost-effective cancer detection in low-volume liquid biopsies},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adp1704}
}
EUVIMED